1. Schwartzentruber, Jeremy, Cooper, Sarah, Liu, Jimmy Z, Beltrao, Pedro, Bassett, Andrew. 2021. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes. In Nature genetics, 53, 392-402. doi:10.1038/s41588-020-00776-w. https://pubmed.ncbi.nlm.nih.gov/33589840/
2. Pakzad, Bahram, Moghadammanesh, Hamed, Salesi, Mansour, Salehi, Rasoul. . Strong Association of Polymorphism in SPRED2 Gene with Disease Susceptibility and Clinical Characteristics of Rheumatoid Arthritis in the Iranian Population. In Avicenna journal of medical biotechnology, 14, 170-174. doi:10.18502/ajmb.v14i2.8888. https://pubmed.ncbi.nlm.nih.gov/35633988/
3. Gao, Tong, Yang, Xu, Fujisawa, Masayoshi, Yoshimura, Teizo, Matsukawa, Akihiro. 2023. SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells. In International journal of molecular sciences, 24, . doi:10.3390/ijms24054996. https://pubmed.ncbi.nlm.nih.gov/36902429/
4. Wang, Hao, Liu, Shuchen, Kong, Fanxuan, Wang, Lisheng, Yang, Yuefeng. 2020. Spred2 inhibits epithelial‑mesenchymal transition of colorectal cancer cells by impairing ERK signaling. In Oncology reports, 44, 174-184. doi:10.3892/or.2020.7586. https://pubmed.ncbi.nlm.nih.gov/32319644/
5. Lopez, Jocelyne, Bonsor, Daniel A, Sale, Matthew J, Simanshu, Dhirendra K, McCormick, Frank. 2023. The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling. In The Journal of biological chemistry, 299, 104789. doi:10.1016/j.jbc.2023.104789. https://pubmed.ncbi.nlm.nih.gov/37149146/
智鼠故事 
